EP2350917A4 - Ovarialkarzinom-biomarker und ihre verwendung - Google Patents

Ovarialkarzinom-biomarker und ihre verwendung

Info

Publication number
EP2350917A4
EP2350917A4 EP09819761A EP09819761A EP2350917A4 EP 2350917 A4 EP2350917 A4 EP 2350917A4 EP 09819761 A EP09819761 A EP 09819761A EP 09819761 A EP09819761 A EP 09819761A EP 2350917 A4 EP2350917 A4 EP 2350917A4
Authority
EP
European Patent Office
Prior art keywords
biomarkers
ovarian cancer
ovarian
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09819761A
Other languages
English (en)
French (fr)
Other versions
EP2350917A1 (de
Inventor
Larry Gold
Marty Stanton
Edward N Brody
Rachel M Ostroff
Dominic Zichi
Alex A E Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somalogic Inc
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of EP2350917A1 publication Critical patent/EP2350917A1/de
Publication of EP2350917A4 publication Critical patent/EP2350917A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Evolutionary Computation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Urology & Nephrology (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Biophysics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP09819761A 2008-10-06 2009-10-06 Ovarialkarzinom-biomarker und ihre verwendung Withdrawn EP2350917A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10314908P 2008-10-06 2008-10-06
PCT/US2009/059706 WO2010042525A1 (en) 2008-10-06 2009-10-06 Ovarian cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
EP2350917A1 EP2350917A1 (de) 2011-08-03
EP2350917A4 true EP2350917A4 (de) 2012-06-06

Family

ID=42076103

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09819761A Withdrawn EP2350917A4 (de) 2008-10-06 2009-10-06 Ovarialkarzinom-biomarker und ihre verwendung

Country Status (4)

Country Link
EP (1) EP2350917A4 (de)
AU (1) AU2009302537A1 (de)
CA (1) CA2737004A1 (de)
WO (1) WO2010042525A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2603622A4 (de) 2010-08-13 2015-04-22 Somalogic Inc Biomarker für bauchspeicheldrüsenkrebs und verwendungen davon
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
CA2956723C (en) 2014-08-12 2023-04-11 Nextgen Jane, Inc. System and method for monitoring health based on collected bodily fluid
EP3442706B1 (de) 2016-04-13 2025-07-23 NextGen Jane, Inc. Probensammel- und konservierungsverfahren
WO2019210052A1 (en) * 2018-04-27 2019-10-31 Laboratory Corporation Of America Holdings Methods and systems for determining the risk of developing ovarian cancer
CN110244733B (zh) * 2019-06-20 2020-06-30 西南交通大学 一种基于改进蚁群算法的移动机器人路径规划方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069963A1 (en) * 2003-08-15 2005-03-31 Lokshin Anna E. Multifactorial assay for cancer detection
US20070212721A1 (en) * 2006-01-27 2007-09-13 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294377A1 (en) * 2002-12-18 2004-07-29 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
EP3153860A3 (de) * 2005-12-22 2017-06-14 Abbott Molecular Inc. Verfahren und markerkombinationen zur untersuchung auf veranlagung von lungenkrebs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069963A1 (en) * 2003-08-15 2005-03-31 Lokshin Anna E. Multifactorial assay for cancer detection
US20070212721A1 (en) * 2006-01-27 2007-09-13 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOCK ET AL: "Photoaptamer arrays applied to multiplexed proteomic analysis", PROTEOMICS,, vol. 4, no. 3, 1 March 2004 (2004-03-01), pages 609 - 618, XP008109809, DOI: 10.1002/PMIC.200300631 *
See also references of WO2010042525A1 *

Also Published As

Publication number Publication date
WO2010042525A1 (en) 2010-04-15
EP2350917A1 (de) 2011-08-03
CA2737004A1 (en) 2010-04-15
AU2009302537A1 (en) 2010-04-15
WO2010042525A9 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
EP2603622A4 (de) Biomarker für bauchspeicheldrüsenkrebs und verwendungen davon
EP2340506A4 (de) Biomarker für lungenkrebs und verwendung
EP2771692A4 (de) Biomarker für lungenkrebs und verwendung
EP2263087A4 (de) Markierte reaktanden und ihre verwendung
EP2504439A4 (de) Optimierte endonukleasen und ihre verwendung
EP2171453A4 (de) Ovarialkarzinom-vorhersagemarker
EP2616445A4 (de) Östrogenrezeptormodulatoren und verwendungen davon
EP2426110A4 (de) Pyrazolyl-acrylnitril-verbindungen und ihre verwendungen
EP2622104A4 (de) Biomarker für mesotheliome und verwendungen davon
EP2445894A4 (de) Ketalverbindungen und deren verwendungen
EP2365962A4 (de) Aminoalkohollipidoide und anwendungen davon
EP2318429A4 (de) Prominin-1 peptidfragmente und ihre verwendung
EP2467141A4 (de) Heterocyclische verbindungen und ihre verwendung
EP2265950A4 (de) Nachweis von biomarkern und biomarker-komplexen
EP2605789A4 (de) Modifizierte relaxinpolypeptide und ihre verwendungen
EP2281006A4 (de) Vernetzer und ihre verwendung
PL2733492T3 (pl) Sposób wykrywania nowotworów
EP2185698A4 (de) Kinasehemmer und ihre verwendung
EP2173370A4 (de) Oligopeptid-tyrosinase-inhibitoren und ihre verwendungen
EP2640792A4 (de) Klebstoffzusammensetzungen und ihre verwendung
EP2646446A4 (de) Bromodomainhemmer und ihre verwendung
EP2158221A4 (de) Kovalente diabodies und deren verwendung
EP2638009A4 (de) Fluorinierte hdac-hemmer und verwendungen davon
EP2805167A4 (de) Biomarker für magenkrebs und verwendungen davon
EP2483292A4 (de) Variante lov-d-polypeptide und ihre verwendungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110421

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120507

RIC1 Information provided on ipc code assigned before grant

Ipc: G06G 7/58 20060101AFI20120501BHEP

Ipc: G01N 33/50 20060101ALI20120501BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150501